EUVIMEDEUVIMED entdecken
Crossref

Taraxasterol ameliorates bone loss of ovariectomized mice via suppressing the NLRP3 inflammasome and modulating the gut microbiota

Yanming Liu, Shihui Liang, Yitao Lei, Yilin Zhou, Yingtong Zhang, Shimei Li, Ping Sun, Qunwei Dong

Biochemical and Biophysical Research Communications · 2026-03 · 806 · 153404

DOI: 10.1016/j.bbrc.2026.153404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-03. Verfasst von Yanming Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510000, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Gastrointestinal Microbiome, Triterpenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Traditional Chinese Medicine Bureau of Guangdong Province, Guangzhou Municipal Science and Technology Project, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal osteoporosis (PMOP) is a common disease linked to aging, and estrogen deficiency is considered to be the primary cause of PMOP. Inflammation and the gut microbiota (GM) have emerged as promising therapeutic targets for treating PMOP. Taraxasterol (Tara), a pentacyclic triterpenoid primarily derived from Taraxacum officinale, demonstrates broad biological functions and pharmacological properties. However, whether Tara in question exerts an anti-osteoporosis (OP) effect remains unclear. To investigate the potential anti-OP effects of Tara, an experimental OP model was developed using female C57BL/6 mice via bilateral ovariectomy (OVX). The mice of Tara groups received treatments via oral gavage once daily for 8 consecutive weeks. Bone microstructure parameters, the NLRP3 inflammasome, intestinal barrier and GM were assessed. Network pharmacology was employed to predict and validate its anti-OP-related molecular targets and pathways. The results revealed that Tara treatment significantly reduced bone loss and improved bone metabolism. ELISA revealed that Tara reduced proinflammatory cytokine levels, suppressed the NLRP3 inflammasome (caspase-1, IL-1β and IL-18) and affected adipokine content. The expression levels of Occludin and ZO-1 exhibited a significant increase in the Tara groups. Moreover, 16S rRNA sequencing demonstrated that the relative abundances of Ileibacterium, Erysipelotrichaceae and Oscillospiraceae decreased significantly, whereases the relative abundance of Parabacteroides increased after Tara administration. Network pharmacology identified 75 core anti-OP targets. The binding energy of target proteins and Tara ranged from approximately -5.0 to -9.0 kcal/mol, with EGFR showing the lowest binding energy. Overall, Tara ameliorated OVX-induced OP by suppressing the NLRP3 inflammasome and modulating the GM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesGastrointestinal MicrobiomeTriterpenesSterolsOsteoporosis, PostmenopausalAnimalsFemaleOvariectomyMice, Inbred C57BLMice

Stichwörter der Autor:innen

Gut microbiotaNLRP3 inflammasomePostmenopausal osteoporosisTaraxasterol

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, mousetaraxasterolTriterpenesSterols

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510000, China.
  • Huanghuagang Street Community Health Service Center, Guangzhou, Guangdong, 510095, China.
  • Department of Endocrinology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510000, China. Electronic address: sing_ping928@gdpu.edu.cn.
  • Department of Endocrinology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510000, China. Electronic address: dongqunwei@126.com.

Förderung

  • Traditional Chinese Medicine Bureau of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Liu, Y., Liang, S., Lei, Y., Zhou, Y., Zhang, Y., Li, S., Sun, P., & Dong, Q. (2026). Taraxasterol ameliorates bone loss of ovariectomized mice via suppressing the NLRP3 inflammasome and modulating the gut microbiota. Biochemical and Biophysical Research Communications, 806, 153404. https://doi.org/10.1016/j.bbrc.2026.153404

Vancouver

Liu Y, Liang S, Lei Y, Zhou Y, Zhang Y, Li S, et al. Taraxasterol ameliorates bone loss of ovariectomized mice via suppressing the NLRP3 inflammasome and modulating the gut microbiota. Biochemical and Biophysical Research Communications. 2026;806:153404. doi:10.1016/j.bbrc.2026.153404

BibTeX
@article{Liu2026,
  author = {Liu, Yanming and Liang, Shihui and Lei, Yitao and Zhou, Yilin and Zhang, Yingtong and Li, Shimei and Sun, Ping and Dong, Qunwei},
  title = {Taraxasterol ameliorates bone loss of ovariectomized mice via suppressing the NLRP3 inflammasome and modulating the gut microbiota},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {806},
  pages = {153404},
  doi = {10.1016/j.bbrc.2026.153404}
}
Kostenlos starten →